focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 375.00
Bid: 376.00
Ask: 377.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.266%)
Open: 375.00
High: 376.00
Low: 375.00
Prev. Close: 375.00
WIL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year-end Trading Update

20 Jul 2021 07:00

RNS Number : 7378F
Wilmington PLC
20 July 2021
 

20 July 2021

Wilmington plc

 

Year-end trading update - ahead of expectations

 

Wilmington plc, (LSE: WIL, 'Wilmington' or 'the Group') the provider of data, information, education and training services in the global Governance, Risk and Compliance (GRC) markets, today provides a trading update for the year ended 30 June 2021.

 

Wilmington ended the year ahead of expectations for revenue, Adjusted PBT* and net debt.

 

Trading in both the Information & Data, and Training & Education divisions was strong in H2 resulting in Group revenue for the year being unchanged, despite the lack of face-to-face training or events. Revenues excluding events have grown year-on-year in both divisions, underlining the strength of the Wilmington franchise.

 

Full-year adjusted profits are ahead of FY20 as the Group benefitted from the swift digitisation of its products and services at the beginning of the Covid pandemic, strong revenues, tight control of overheads and actions taken to reduce less profitable lines of business.

 

Cash flows have also been notably strong with Group net debt at 30 June 2021 down to £17.7m (30 June 2020: £27.7m).

 

Wilmington expects to publish its year end results during the week commencing 20 September 2021.

 

Mark Milner, Chief Executive Officer, commented:

 

"This robust performance, despite the pandemic which resulted in all our products needing to be delivered digitally, reflects the restructuring and repositioning that we executed over the last year or so and our leading market positions.

 

"Importantly, cash flow was also strong, which has enabled us to continue to invest in new products, reduce debt, repay the UK furlough support and resume paying dividends.

 

"We operate in large GRC and Regulatory Compliance markets with strong growth characteristics. Our new structure and operating model support our clear strategy to focus on our core purpose of helping our customers to do the right business in the right way.

 

"The resilient nature of our digital business delivery, the gradual return of face-to-face training and events and our investment in new products and capabilities means we expect both revenues and profits to make good progress in the new financial year."

 

*Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation of intangible assets except computer software and profits/losses on disposals and business closures.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGMNNLGGMZM
Date   Source Headline
1st Nov 20182:07 pmRNSResult of AGM
1st Nov 20187:00 amRNSAGM Statement and Q1 Trading Update
1st Nov 20187:00 amRNSTotal Voting Rights
17th Oct 20185:13 pmRNSHolding(s) in Company
1st Oct 20185:44 pmRNSDirector/PDMR Shareholding
1st Oct 201810:18 amRNSTotal Voting Rights
25th Sep 201812:29 pmRNSHolding(s) in Company
21st Sep 20183:13 pmRNSDirector/PDMR Shareholding
20th Sep 20183:19 pmRNSDirector/PDMR Shareholding
19th Sep 20182:12 pmRNSShare Awards
12th Sep 20187:00 amRNSFinancial results for the year ended 30 June 2018
3rd Sep 20189:00 amRNSTotal Voting Rights
28th Aug 201810:39 amRNSHolding(s) in Company
1st Aug 20189:00 amRNSTotal Voting Rights
19th Jul 20187:00 amRNSSale of ICP Credit Reporting Business
10th Jul 20184:24 pmRNSHolding(s) in Company
10th Jul 20184:19 pmRNSHolding(s) in Company
9th Jul 20182:23 pmRNSHolding(s) in Company
6th Jul 20187:00 amRNSTrading Statement
2nd Jul 201810:29 amRNSVoting Rights and Capital
1st Jun 20189:00 amRNSTotal Voting Rights
9th May 20187:00 amRNSCapital Markets Day
1st May 20187:00 amRNSTotal Voting Rights
3rd Apr 20187:00 amRNSVoting Rights and Capital
19th Mar 20184:18 pmRNSBoard Change - Correction
19th Mar 201811:34 amRNSHolding(s) in Company
16th Mar 20181:06 pmRNSBoard Change
15th Mar 20183:36 pmRNSHolding(s) in Company
2nd Mar 20182:13 pmRNSDirector/PDMR Shareholding
1st Mar 20189:00 amRNSVoting Rights and Capital
26th Feb 20188:34 amRNSDirector/PDMR Shareholding
22nd Feb 20183:49 pmRNSHolding(s) in Company
22nd Feb 20187:00 amRNSInterim Results
22nd Feb 20187:00 amRNSAppointment of Martin Morgan as Chairman
14th Feb 20182:50 pmRNSHolding(s) in Company
1st Feb 20189:10 amRNSHolding(s) in Company
1st Feb 20189:00 amRNSVoting Rights and Capital
4th Jan 20187:00 amRNSAcquisition of Interactive Medica
2nd Jan 20189:00 amRNSVoting Rights and Capital
18th Dec 20174:43 pmRNSNotification of Interim Results
1st Dec 20177:00 amRNSVoting Rights and Capital
29th Nov 20177:00 amRNSAppointment of new Chief Financial Officer
23rd Nov 201710:34 amRNSDirector/PDMR Shareholding
2nd Nov 20172:43 pmRNSResult of AGM
2nd Nov 20177:00 amRNSAGM and Q1 Trading Update
1st Nov 20179:12 amRNSVoting Rights and Capital
6th Oct 20175:58 pmRNSHolding(s) in Company
5th Oct 20173:45 pmRNSHolding(s) in Company
5th Oct 20173:44 pmRNSHolding(s) in Company
2nd Oct 20172:49 pmRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.